JMCCX
Price
$60.42
Change
+$0.04 (+0.07%)
Updated
Nov 12 closing price
Net Assets
5.8B
VIMSX
Price
$79.76
Change
+$0.02 (+0.03%)
Updated
Nov 12 closing price
Net Assets
198.55B
Interact to see
Advertisement

JMCCX vs VIMSX

Header iconJMCCX vs VIMSX Comparison
Open Charts JMCCX vs VIMSXBanner chart's image
JPMorgan Mid Cap Equity C
Price$60.42
Change+$0.04 (+0.07%)
VolumeN/A
Net Assets5.8B
Vanguard Mid Cap Index Investor
Price$79.76
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets198.55B
JMCCX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
JMCCX vs. VIMSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMCCX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. JMCCX (5.8B). VIMSX pays higher dividends than JMCCX: VIMSX (1.38) vs JMCCX (0.00). JMCCX was incepted earlier than VIMSX: JMCCX (16 years) vs VIMSX (28 years). JMCCX (1.72) is less costly to investors than VIMSX (0.17). JMCCX is a more actively managed with annual turnover of: 61.00 vs. VIMSX (16.00). JMCCX has a lower initial minimum investment than VIMSX: JMCCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 5.67 vs. JMCCX (-3.25). VIMSX return over 5 years is better than : 52.23 vs. JMCCX (12.91).
JMCCXVIMSXJMCCX / VIMSX
Total Expense Ratio1.590.17935%
Annual Report Gross Expense Ratio1.720.171,012%
Fund Existence16 years28 years-
Gain YTD5.48210.76451%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets5.8B199B3%
Annual Yield % from dividends0.001.38-
Returns for 1 year-3.255.67-57%
Returns for 3 years24.7837.8266%
Returns for 5 years12.9152.2325%
Returns for 10 years41.50148.8328%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QVCGA6.950.67
+10.67%
QVC Group Inc
GALT5.830.33
+6.00%
Galectin Therapeutics
RGEN158.014.57
+2.98%
Repligen Corp
BHFAP16.56-0.14
-0.84%
Brighthouse Financial
LSPD12.79-0.36
-2.74%
Lightspeed Commerce